Pharmacogenetic profiling of CD133 is associated with response rate (RR) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC), treated with bevacizumab-based chemotherapy

CD133+ human umbilical cord blood stem cells enhance angiogenesis in experimental chronic hepatic fibrosis

(2010) NAGWA ELKHAFIF et al.   APMIS

Glioblastoma stem-like cells give rise to tumour endothelium

(2010) Rong Wang et al.   NATURE

Formação in vitro de túbulos capilares a partir de células de sangue de cordão umbilical humano com perspectivas para aplicação terapêutica

(2010) Alexandra Cristina Senegaglia et al.   Revista Brasileira de Cirurgia Cardiovascular

Human CD133 + Progenitor Cells Promote the Healing of Diabetic Ischemic Ulcers by Paracrine Stimulation of Angiogenesis and Activation of Wnt Signaling

(2009) Lucíola S. Barcelos et al.   CIRCULATION RESEARCH

Targeting CD133 antigen in cancer

(2009) Gabriella Ferrandina et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

CD133+CD44+ Population Efficiently Enriches Colon Cancer Initiating Cells

(2008) Naotsugu Haraguchi et al.   ANNALS OF SURGICAL ONCOLOGY

Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87

(2008) Shi-cang Yu et al.   CANCER LETTERS

Polymorphisms in Cyclooxygenase-2 and Epidermal Growth Factor Receptor Are Associated with Progression-Free Survival Independent of K-ras in Metastatic Colorectal Cancer Patients Treated with Single-Agent Cetuximab

(2008) G. Lurje et al.   CLINICAL CANCER RESEARCH

Stem Cells in Colon Cancer

(2008) Alexandra Pohl et al.   Clinical Colorectal Cancer

Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation

(2008) Liqin Zhu et al.   NATURE